Bonus Issue Announcement – Biogen Pharmachem Industries Limited

Biogen Pharmachem Industries Limited has announced a bonus issue of equity shares, as per a recent notice issued by the Bombay Stock Exchange (BSE).

Key Highlights:

● Bonus Ratio:
1:1 (1 bonus equity share for every 1 existing equity share held)

● Face Value:
₹1 per share

● Record Date:
15 May 2026
(Shareholders holding shares as of this date will be eligible for the bonus issue)

● Ex-Bonus Date:
15 May 2026

● Allotment Date:
On or before 18 May 2026

Additional Information:

● A total of 15,04,33,833 equity shares are expected to be allotted under this bonus issue.

● The corporate action falls under the Equity segment and is managed by the Listing Operations Department of BSE.

What This Means for Investors

A bonus issue increases the number of shares held by investors without any additional cost, while proportionately adjusting the stock price. It is generally viewed as a positive indicator of the company’s confidence in its business outlook and commitment to enhancing shareholder value.